A Trial Investigating Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of a Single Dose of Long-acting Growth Hormone (Somapacitan) Compared to Daily Dosing of Norditropin® SimpleXx® in Children With Growth Hormone Deficiency
Clinical trial NCT01973244 · COMPLETED
Trial details
- NCT number
- NCT01973244
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-12-16
- Primary completion
- 2014-11-04
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.